nodes	percent_of_prediction	percent_of_DWPC	metapath
Reboxetine—HTR2C—migraine	0.199	0.547	CbGaD
Reboxetine—SLC6A4—migraine	0.165	0.453	CbGaD
Reboxetine—Atomoxetine—Propranolol—migraine	0.0822	0.359	CrCrCtD
Reboxetine—Orphenadrine—Amitriptyline—migraine	0.0776	0.339	CrCrCtD
Reboxetine—Diphenhydramine—Amitriptyline—migraine	0.0689	0.301	CrCrCtD
Reboxetine—SLC6A4—Amitriptyline—migraine	0.0436	0.156	CbGbCtD
Reboxetine—HTR2C—Amitriptyline—migraine	0.0365	0.131	CbGbCtD
Reboxetine—SLC6A2—Amitriptyline—migraine	0.0365	0.131	CbGbCtD
Reboxetine—SLC6A4—Verapamil—migraine	0.0346	0.124	CbGbCtD
Reboxetine—ABCB1—Timolol—migraine	0.0151	0.0539	CbGbCtD
Reboxetine—CYP2D6—Timolol—migraine	0.0142	0.0508	CbGbCtD
Reboxetine—ABCB1—Propranolol—migraine	0.0134	0.048	CbGbCtD
Reboxetine—CYP2D6—Propranolol—migraine	0.0127	0.0452	CbGbCtD
Reboxetine—ABCB1—Amitriptyline—migraine	0.0116	0.0415	CbGbCtD
Reboxetine—CYP2D6—Amitriptyline—migraine	0.0109	0.0391	CbGbCtD
Reboxetine—ABCB1—Verapamil—migraine	0.00922	0.033	CbGbCtD
Reboxetine—CYP2D6—Verapamil—migraine	0.00868	0.0311	CbGbCtD
Reboxetine—CYP3A4—Propranolol—migraine	0.00805	0.0288	CbGbCtD
Reboxetine—CYP3A4—Amitriptyline—migraine	0.00696	0.0249	CbGbCtD
Reboxetine—CYP3A4—Valproic Acid—migraine	0.00634	0.0227	CbGbCtD
Reboxetine—CYP3A4—Topiramate—migraine	0.00572	0.0205	CbGbCtD
Reboxetine—CYP3A4—Verapamil—migraine	0.00552	0.0197	CbGbCtD
Reboxetine—SLC6A2—locus ceruleus—migraine	0.00255	0.221	CbGeAlD
Reboxetine—SLC6A2—sympathetic nervous system—migraine	0.00202	0.175	CbGeAlD
Reboxetine—SLC6A2—autonomic nervous system—migraine	0.00136	0.117	CbGeAlD
Reboxetine—HTR2C—Serotonin receptors—HTR1D—migraine	0.00124	0.0702	CbGpPWpGaD
Reboxetine—HTR2C—Serotonin receptors—HTR2B—migraine	0.00115	0.0652	CbGpPWpGaD
Reboxetine—SLC6A4—Synaptic Vesicle Pathway—ATP1A2—migraine	0.000808	0.0459	CbGpPWpGaD
Reboxetine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2B—migraine	0.000763	0.0433	CbGpPWpGaD
Reboxetine—SLC6A2—nerve—migraine	0.000763	0.066	CbGeAlD
Reboxetine—HTR2C—Serotonin receptors—HTR1B—migraine	0.000749	0.0425	CbGpPWpGaD
Reboxetine—HTR2C—Serotonin receptors—HTR1A—migraine	0.000721	0.0409	CbGpPWpGaD
Reboxetine—HTR2C—Serotonin receptors—HTR7—migraine	0.00061	0.0346	CbGpPWpGaD
Reboxetine—SLC6A4—Synaptic Vesicle Pathway—CACNA1A—migraine	0.000584	0.0332	CbGpPWpGaD
Reboxetine—HTR2C—Monoamine GPCRs—HTR1D—migraine	0.00055	0.0312	CbGpPWpGaD
Reboxetine—Atomoxetine—HTR1D—migraine	0.000535	0.27	CrCbGaD
Reboxetine—HTR2C—Monoamine GPCRs—HTR2B—migraine	0.000511	0.029	CbGpPWpGaD
Reboxetine—Orphenadrine—SCN1A—migraine	0.000495	0.249	CrCbGaD
Reboxetine—HTR2C—Amine ligand-binding receptors—HTR1D—migraine	0.000462	0.0263	CbGpPWpGaD
Reboxetine—HTR2C—Amine ligand-binding receptors—HTR2B—migraine	0.00043	0.0244	CbGpPWpGaD
Reboxetine—HTR2C—Serotonin receptors—HTR2A—migraine	0.000427	0.0242	CbGpPWpGaD
Reboxetine—SLC6A2—Monoamine Transport—SLC6A4—migraine	0.000394	0.0224	CbGpPWpGaD
Reboxetine—HTR2C—brainstem—migraine	0.000392	0.0339	CbGeAlD
Reboxetine—SLC6A4—brainstem—migraine	0.000372	0.0322	CbGeAlD
Reboxetine—HTR2C—Monoamine GPCRs—HTR1B—migraine	0.000333	0.0189	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—ATP1A3—migraine	0.00033	0.0188	CbGpPWpGaD
Reboxetine—SLC6A2—brainstem—migraine	0.000327	0.0283	CbGeAlD
Reboxetine—HTR2C—Monoamine GPCRs—HTR1A—migraine	0.000321	0.0182	CbGpPWpGaD
Reboxetine—Atomoxetine—HTR1B—migraine	0.000318	0.16	CrCbGaD
Reboxetine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—migraine	0.000284	0.0161	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—HTR3A—migraine	0.000281	0.016	CbGpPWpGaD
Reboxetine—HTR2C—Amine ligand-binding receptors—HTR1B—migraine	0.00028	0.0159	CbGpPWpGaD
Reboxetine—HTR2C—Monoamine GPCRs—HTR7—migraine	0.000271	0.0154	CbGpPWpGaD
Reboxetine—HTR2C—Amine ligand-binding receptors—HTR1A—migraine	0.00027	0.0153	CbGpPWpGaD
Reboxetine—Atomoxetine—HTR2C—migraine	0.000259	0.13	CrCbGaD
Reboxetine—ABCB1—blood vessel—migraine	0.000236	0.0204	CbGeAlD
Reboxetine—HTR2C—Amine ligand-binding receptors—HTR7—migraine	0.000228	0.013	CbGpPWpGaD
Reboxetine—HTR2C—head—migraine	0.000217	0.0188	CbGeAlD
Reboxetine—Atomoxetine—SLC6A4—migraine	0.000215	0.108	CrCbGaD
Reboxetine—HTR2C—nervous system—migraine	0.000206	0.0178	CbGeAlD
Reboxetine—SLC6A4—head—migraine	0.000206	0.0178	CbGeAlD
Reboxetine—HTR2C—central nervous system—migraine	0.000198	0.0171	CbGeAlD
Reboxetine—SLC6A4—nervous system—migraine	0.000195	0.0169	CbGeAlD
Reboxetine—HTR2C—Monoamine GPCRs—HTR2A—migraine	0.00019	0.0108	CbGpPWpGaD
Reboxetine—SLC6A4—central nervous system—migraine	0.000188	0.0162	CbGeAlD
Reboxetine—SLC6A2—head—migraine	0.000181	0.0157	CbGeAlD
Reboxetine—CYP2D6—brainstem—migraine	0.000179	0.0155	CbGeAlD
Reboxetine—SLC6A2—nervous system—migraine	0.000172	0.0148	CbGeAlD
Reboxetine—SLC6A2—central nervous system—migraine	0.000165	0.0143	CbGeAlD
Reboxetine—Atomoxetine—HTR2A—migraine	0.000165	0.083	CrCbGaD
Reboxetine—HTR2C—Amine ligand-binding receptors—HTR2A—migraine	0.00016	0.00907	CbGpPWpGaD
Reboxetine—HTR2C—brain—migraine	0.000157	0.0136	CbGeAlD
Reboxetine—SLC6A4—brain—migraine	0.000149	0.0129	CbGeAlD
Reboxetine—ABCB1—trigeminal ganglion—migraine	0.000146	0.0126	CbGeAlD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—HTR1A—migraine	0.000134	0.00758	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—TAC1—migraine	0.000132	0.00747	CbGpPWpGaD
Reboxetine—SLC6A2—brain—migraine	0.000131	0.0113	CbGeAlD
Reboxetine—HTR2C—G alpha (q) signalling events—HTR2B—migraine	0.000128	0.00725	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—TRPM8—migraine	0.000127	0.00719	CbGpPWpGaD
Reboxetine—SLC6A4—Monoamine Transport—TNF—migraine	0.000121	0.00686	CbGpPWpGaD
Reboxetine—SLC6A2—NRF2 pathway—SLC6A4—migraine	0.000117	0.00664	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2B—migraine	0.000114	0.00648	CbGpPWpGaD
Reboxetine—Urinary tract disorder—Gabapentin—migraine	0.00011	0.00114	CcSEcCtD
Reboxetine—Tremor—Valproic Acid—migraine	0.00011	0.00114	CcSEcCtD
Reboxetine—Dysuria—Topiramate—migraine	0.00011	0.00114	CcSEcCtD
Reboxetine—Connective tissue disorder—Gabapentin—migraine	0.00011	0.00114	CcSEcCtD
Reboxetine—Urethral disorder—Gabapentin—migraine	0.000109	0.00113	CcSEcCtD
Reboxetine—Ill-defined disorder—Valproic Acid—migraine	0.000109	0.00113	CcSEcCtD
Reboxetine—Angiopathy—Timolol—migraine	0.000109	0.00113	CcSEcCtD
Reboxetine—Pollakiuria—Topiramate—migraine	0.000108	0.00112	CcSEcCtD
Reboxetine—Anaemia—Valproic Acid—migraine	0.000108	0.00112	CcSEcCtD
Reboxetine—Immune system disorder—Timolol—migraine	0.000108	0.00112	CcSEcCtD
Reboxetine—Hypersensitivity—Propranolol—migraine	0.000108	0.00112	CcSEcCtD
Reboxetine—Erectile dysfunction—Topiramate—migraine	0.000108	0.00112	CcSEcCtD
Reboxetine—Mediastinal disorder—Timolol—migraine	0.000108	0.00112	CcSEcCtD
Reboxetine—Agitation—Valproic Acid—migraine	0.000108	0.00112	CcSEcCtD
Reboxetine—Visual impairment—Gabapentin—migraine	0.000107	0.00111	CcSEcCtD
Reboxetine—SLC6A4—Circadian rythm related genes—NPS—migraine	0.000107	0.0061	CbGpPWpGaD
Reboxetine—Urticaria—Verapamil—migraine	0.000107	0.00111	CcSEcCtD
Reboxetine—Nausea—Amitriptyline—migraine	0.000107	0.00111	CcSEcCtD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1D—migraine	0.000106	0.00603	CbGpPWpGaD
Reboxetine—Weight decreased—Topiramate—migraine	0.000106	0.0011	CcSEcCtD
Reboxetine—Hyperglycaemia—Topiramate—migraine	0.000106	0.0011	CcSEcCtD
Reboxetine—Malaise—Valproic Acid—migraine	0.000106	0.00109	CcSEcCtD
Reboxetine—ABCB1—cardiovascular system—migraine	0.000105	0.0091	CbGeAlD
Reboxetine—Vertigo—Valproic Acid—migraine	0.000105	0.00109	CcSEcCtD
Reboxetine—Asthenia—Propranolol—migraine	0.000105	0.00109	CcSEcCtD
Reboxetine—Mental disorder—Timolol—migraine	0.000105	0.00109	CcSEcCtD
Reboxetine—Leukopenia—Valproic Acid—migraine	0.000105	0.00109	CcSEcCtD
Reboxetine—Infestation—Topiramate—migraine	0.000104	0.00108	CcSEcCtD
Reboxetine—Infestation NOS—Topiramate—migraine	0.000104	0.00108	CcSEcCtD
Reboxetine—Malnutrition—Timolol—migraine	0.000104	0.00108	CcSEcCtD
Reboxetine—Eye disorder—Gabapentin—migraine	0.000104	0.00108	CcSEcCtD
Reboxetine—SLC6A2—Monoamine Transport—TNF—migraine	0.000104	0.0059	CbGpPWpGaD
Reboxetine—Tinnitus—Gabapentin—migraine	0.000104	0.00108	CcSEcCtD
Reboxetine—Cardiac disorder—Gabapentin—migraine	0.000103	0.00107	CcSEcCtD
Reboxetine—Palpitations—Valproic Acid—migraine	0.000103	0.00107	CcSEcCtD
Reboxetine—SLC6A4—NRF2 pathway—TGFBR2—migraine	0.000103	0.00583	CbGpPWpGaD
Reboxetine—Tension—Timolol—migraine	0.000102	0.00106	CcSEcCtD
Reboxetine—Dysgeusia—Timolol—migraine	0.000102	0.00106	CcSEcCtD
Reboxetine—Urinary tract infection—Topiramate—migraine	0.000102	0.00105	CcSEcCtD
Reboxetine—Conjunctivitis—Topiramate—migraine	0.000102	0.00105	CcSEcCtD
Reboxetine—Nervousness—Timolol—migraine	0.000101	0.00105	CcSEcCtD
Reboxetine—Hypertension—Valproic Acid—migraine	0.000101	0.00105	CcSEcCtD
Reboxetine—Immune system disorder—Gabapentin—migraine	0.000101	0.00104	CcSEcCtD
Reboxetine—Mediastinal disorder—Gabapentin—migraine	0.0001	0.00104	CcSEcCtD
Reboxetine—Diarrhoea—Propranolol—migraine	0.0001	0.00104	CcSEcCtD
Reboxetine—Chills—Gabapentin—migraine	0.0001	0.00104	CcSEcCtD
Reboxetine—Chest pain—Valproic Acid—migraine	9.96e-05	0.00103	CcSEcCtD
Reboxetine—Anxiety—Valproic Acid—migraine	9.93e-05	0.00103	CcSEcCtD
Reboxetine—Hypersensitivity—Verapamil—migraine	9.93e-05	0.00103	CcSEcCtD
Reboxetine—CYP2D6—head—migraine	9.91e-05	0.00857	CbGeAlD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Valproic Acid—migraine	9.9e-05	0.00103	CcSEcCtD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2B—migraine	9.87e-05	0.0056	CbGpPWpGaD
Reboxetine—Epistaxis—Topiramate—migraine	9.85e-05	0.00102	CcSEcCtD
Reboxetine—Discomfort—Valproic Acid—migraine	9.84e-05	0.00102	CcSEcCtD
Reboxetine—Sinusitis—Topiramate—migraine	9.8e-05	0.00102	CcSEcCtD
Reboxetine—Mental disorder—Gabapentin—migraine	9.76e-05	0.00101	CcSEcCtD
Reboxetine—Dry mouth—Valproic Acid—migraine	9.74e-05	0.00101	CcSEcCtD
Reboxetine—Malnutrition—Gabapentin—migraine	9.7e-05	0.00101	CcSEcCtD
Reboxetine—Dizziness—Propranolol—migraine	9.68e-05	0.001	CcSEcCtD
Reboxetine—Asthenia—Verapamil—migraine	9.67e-05	0.001	CcSEcCtD
Reboxetine—Confusional state—Valproic Acid—migraine	9.63e-05	0.000999	CcSEcCtD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—ATP1A3—migraine	9.59e-05	0.00545	CbGpPWpGaD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—ATP1A2—migraine	9.59e-05	0.00545	CbGpPWpGaD
Reboxetine—CYP3A4—nervous system—migraine	9.55e-05	0.00826	CbGeAlD
Reboxetine—Bradycardia—Topiramate—migraine	9.55e-05	0.00099	CcSEcCtD
Reboxetine—HTR2C—GPCR ligand binding—CALCRL—migraine	9.53e-05	0.00541	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—RAMP1—migraine	9.53e-05	0.00541	CbGpPWpGaD
Reboxetine—Tension—Gabapentin—migraine	9.52e-05	0.000988	CcSEcCtD
Reboxetine—Dysgeusia—Gabapentin—migraine	9.5e-05	0.000986	CcSEcCtD
Reboxetine—Infection—Valproic Acid—migraine	9.49e-05	0.000984	CcSEcCtD
Reboxetine—Nervousness—Gabapentin—migraine	9.42e-05	0.000977	CcSEcCtD
Reboxetine—Rhinitis—Topiramate—migraine	9.4e-05	0.000975	CcSEcCtD
Reboxetine—CYP2D6—nervous system—migraine	9.39e-05	0.00813	CbGeAlD
Reboxetine—Nervous system disorder—Valproic Acid—migraine	9.37e-05	0.000972	CcSEcCtD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—BDNF—migraine	9.37e-05	0.00532	CbGpPWpGaD
Reboxetine—Vertigo—Timolol—migraine	9.36e-05	0.000971	CcSEcCtD
Reboxetine—Syncope—Timolol—migraine	9.34e-05	0.000969	CcSEcCtD
Reboxetine—Hallucination—Topiramate—migraine	9.33e-05	0.000968	CcSEcCtD
Reboxetine—Tachycardia—Valproic Acid—migraine	9.32e-05	0.000967	CcSEcCtD
Reboxetine—Vomiting—Propranolol—migraine	9.31e-05	0.000966	CcSEcCtD
Reboxetine—Pharyngitis—Topiramate—migraine	9.31e-05	0.000965	CcSEcCtD
Reboxetine—Skin disorder—Valproic Acid—migraine	9.28e-05	0.000962	CcSEcCtD
Reboxetine—Urinary tract disorder—Topiramate—migraine	9.26e-05	0.000961	CcSEcCtD
Reboxetine—Hyperhidrosis—Valproic Acid—migraine	9.23e-05	0.000958	CcSEcCtD
Reboxetine—Rash—Propranolol—migraine	9.23e-05	0.000958	CcSEcCtD
Reboxetine—Dermatitis—Propranolol—migraine	9.23e-05	0.000957	CcSEcCtD
Reboxetine—SLC6A4—Circadian rythm related genes—HTR7—migraine	9.22e-05	0.00524	CbGpPWpGaD
Reboxetine—Diarrhoea—Verapamil—migraine	9.22e-05	0.000956	CcSEcCtD
Reboxetine—Connective tissue disorder—Topiramate—migraine	9.21e-05	0.000956	CcSEcCtD
Reboxetine—Palpitations—Timolol—migraine	9.21e-05	0.000955	CcSEcCtD
Reboxetine—Urethral disorder—Topiramate—migraine	9.19e-05	0.000953	CcSEcCtD
Reboxetine—CYP3A4—central nervous system—migraine	9.19e-05	0.00795	CbGeAlD
Reboxetine—Loss of consciousness—Timolol—migraine	9.16e-05	0.00095	CcSEcCtD
Reboxetine—Anorexia—Valproic Acid—migraine	9.1e-05	0.000944	CcSEcCtD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1D—migraine	9.09e-05	0.00516	CbGpPWpGaD
Reboxetine—Tremor—Gabapentin—migraine	9.09e-05	0.000943	CcSEcCtD
Reboxetine—CYP2D6—central nervous system—migraine	9.04e-05	0.00782	CbGeAlD
Reboxetine—Visual impairment—Topiramate—migraine	9.04e-05	0.000937	CcSEcCtD
Reboxetine—Ill-defined disorder—Gabapentin—migraine	9e-05	0.000934	CcSEcCtD
Reboxetine—Hypertension—Timolol—migraine	9e-05	0.000933	CcSEcCtD
Reboxetine—Anaemia—Gabapentin—migraine	8.97e-05	0.00093	CcSEcCtD
Reboxetine—Hypotension—Valproic Acid—migraine	8.93e-05	0.000926	CcSEcCtD
Reboxetine—Agitation—Gabapentin—migraine	8.92e-05	0.000925	CcSEcCtD
Reboxetine—Dizziness—Verapamil—migraine	8.91e-05	0.000924	CcSEcCtD
Reboxetine—Chest pain—Timolol—migraine	8.87e-05	0.00092	CcSEcCtD
Reboxetine—CYP2D6—cerebellum—migraine	8.84e-05	0.00765	CbGeAlD
Reboxetine—Anxiety—Timolol—migraine	8.84e-05	0.000917	CcSEcCtD
Reboxetine—SLC6A2—NRF2 pathway—TGFBR2—migraine	8.82e-05	0.00501	CbGpPWpGaD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Timolol—migraine	8.81e-05	0.000914	CcSEcCtD
Reboxetine—Discomfort—Timolol—migraine	8.76e-05	0.000909	CcSEcCtD
Reboxetine—Eye disorder—Topiramate—migraine	8.76e-05	0.000909	CcSEcCtD
Reboxetine—Malaise—Gabapentin—migraine	8.75e-05	0.000908	CcSEcCtD
Reboxetine—Tinnitus—Topiramate—migraine	8.74e-05	0.000907	CcSEcCtD
Reboxetine—Vertigo—Gabapentin—migraine	8.72e-05	0.000904	CcSEcCtD
Reboxetine—Cardiac disorder—Topiramate—migraine	8.7e-05	0.000903	CcSEcCtD
Reboxetine—Syncope—Gabapentin—migraine	8.7e-05	0.000903	CcSEcCtD
Reboxetine—Nausea—Propranolol—migraine	8.7e-05	0.000902	CcSEcCtD
Reboxetine—Leukopenia—Gabapentin—migraine	8.68e-05	0.000901	CcSEcCtD
Reboxetine—Dry mouth—Timolol—migraine	8.67e-05	0.0009	CcSEcCtD
Reboxetine—Insomnia—Valproic Acid—migraine	8.64e-05	0.000896	CcSEcCtD
Reboxetine—Paraesthesia—Valproic Acid—migraine	8.58e-05	0.00089	CcSEcCtD
Reboxetine—Palpitations—Gabapentin—migraine	8.57e-05	0.000889	CcSEcCtD
Reboxetine—Confusional state—Timolol—migraine	8.57e-05	0.000889	CcSEcCtD
Reboxetine—Vomiting—Verapamil—migraine	8.57e-05	0.000888	CcSEcCtD
Reboxetine—Loss of consciousness—Gabapentin—migraine	8.53e-05	0.000885	CcSEcCtD
Reboxetine—Dyspnoea—Valproic Acid—migraine	8.52e-05	0.000883	CcSEcCtD
Reboxetine—Angiopathy—Topiramate—migraine	8.51e-05	0.000882	CcSEcCtD
Reboxetine—Rash—Verapamil—migraine	8.49e-05	0.000881	CcSEcCtD
Reboxetine—Somnolence—Valproic Acid—migraine	8.49e-05	0.000881	CcSEcCtD
Reboxetine—Dermatitis—Verapamil—migraine	8.49e-05	0.00088	CcSEcCtD
Reboxetine—Immune system disorder—Topiramate—migraine	8.47e-05	0.000879	CcSEcCtD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2B—migraine	8.45e-05	0.0048	CbGpPWpGaD
Reboxetine—Mediastinal disorder—Topiramate—migraine	8.45e-05	0.000877	CcSEcCtD
Reboxetine—Infection—Timolol—migraine	8.45e-05	0.000876	CcSEcCtD
Reboxetine—Headache—Verapamil—migraine	8.44e-05	0.000875	CcSEcCtD
Reboxetine—Chills—Topiramate—migraine	8.41e-05	0.000873	CcSEcCtD
Reboxetine—Dyspepsia—Valproic Acid—migraine	8.41e-05	0.000872	CcSEcCtD
Reboxetine—Hypertension—Gabapentin—migraine	8.38e-05	0.000869	CcSEcCtD
Reboxetine—Shock—Timolol—migraine	8.37e-05	0.000868	CcSEcCtD
Reboxetine—Nervous system disorder—Timolol—migraine	8.34e-05	0.000865	CcSEcCtD
Reboxetine—Decreased appetite—Valproic Acid—migraine	8.3e-05	0.000861	CcSEcCtD
Reboxetine—Chest pain—Gabapentin—migraine	8.26e-05	0.000857	CcSEcCtD
Reboxetine—Skin disorder—Timolol—migraine	8.26e-05	0.000857	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Valproic Acid—migraine	8.25e-05	0.000855	CcSEcCtD
Reboxetine—Anxiety—Gabapentin—migraine	8.23e-05	0.000854	CcSEcCtD
Reboxetine—Hyperhidrosis—Timolol—migraine	8.22e-05	0.000853	CcSEcCtD
Reboxetine—Mental disorder—Topiramate—migraine	8.22e-05	0.000852	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—migraine	8.2e-05	0.000851	CcSEcCtD
Reboxetine—Constipation—Valproic Acid—migraine	8.17e-05	0.000847	CcSEcCtD
Reboxetine—Malnutrition—Topiramate—migraine	8.16e-05	0.000847	CcSEcCtD
Reboxetine—Discomfort—Gabapentin—migraine	8.16e-05	0.000847	CcSEcCtD
Reboxetine—SLC6A2—Transmembrane transport of small molecules—HTR3A—migraine	8.16e-05	0.00463	CbGpPWpGaD
Reboxetine—Anorexia—Timolol—migraine	8.11e-05	0.000841	CcSEcCtD
Reboxetine—Dry mouth—Gabapentin—migraine	8.08e-05	0.000838	CcSEcCtD
Reboxetine—Tension—Topiramate—migraine	8.01e-05	0.000831	CcSEcCtD
Reboxetine—Nausea—Verapamil—migraine	8e-05	0.00083	CcSEcCtD
Reboxetine—Dysgeusia—Topiramate—migraine	7.99e-05	0.000829	CcSEcCtD
Reboxetine—Confusional state—Gabapentin—migraine	7.98e-05	0.000828	CcSEcCtD
Reboxetine—Hypotension—Timolol—migraine	7.95e-05	0.000824	CcSEcCtD
Reboxetine—Nervousness—Topiramate—migraine	7.93e-05	0.000822	CcSEcCtD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—migraine	7.91e-05	0.00449	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—TAC1—migraine	7.89e-05	0.00448	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—NPS—migraine	7.89e-05	0.00448	CbGpPWpGaD
Reboxetine—Feeling abnormal—Valproic Acid—migraine	7.87e-05	0.000816	CcSEcCtD
Reboxetine—Infection—Gabapentin—migraine	7.87e-05	0.000816	CcSEcCtD
Reboxetine—Gastrointestinal pain—Valproic Acid—migraine	7.81e-05	0.00081	CcSEcCtD
Reboxetine—Shock—Gabapentin—migraine	7.79e-05	0.000808	CcSEcCtD
Reboxetine—Nervous system disorder—Gabapentin—migraine	7.77e-05	0.000805	CcSEcCtD
Reboxetine—Tachycardia—Gabapentin—migraine	7.73e-05	0.000802	CcSEcCtD
Reboxetine—Skin disorder—Gabapentin—migraine	7.69e-05	0.000798	CcSEcCtD
Reboxetine—Insomnia—Timolol—migraine	7.69e-05	0.000798	CcSEcCtD
Reboxetine—Hyperhidrosis—Gabapentin—migraine	7.65e-05	0.000794	CcSEcCtD
Reboxetine—Tremor—Topiramate—migraine	7.65e-05	0.000793	CcSEcCtD
Reboxetine—Paraesthesia—Timolol—migraine	7.64e-05	0.000792	CcSEcCtD
Reboxetine—Urticaria—Valproic Acid—migraine	7.59e-05	0.000787	CcSEcCtD
Reboxetine—Dyspnoea—Timolol—migraine	7.58e-05	0.000786	CcSEcCtD
Reboxetine—Ill-defined disorder—Topiramate—migraine	7.57e-05	0.000786	CcSEcCtD
Reboxetine—Somnolence—Timolol—migraine	7.56e-05	0.000784	CcSEcCtD
Reboxetine—Abdominal pain—Valproic Acid—migraine	7.55e-05	0.000783	CcSEcCtD
Reboxetine—Body temperature increased—Valproic Acid—migraine	7.55e-05	0.000783	CcSEcCtD
Reboxetine—Anorexia—Gabapentin—migraine	7.55e-05	0.000783	CcSEcCtD
Reboxetine—Anaemia—Topiramate—migraine	7.54e-05	0.000783	CcSEcCtD
Reboxetine—HTR2C—G alpha (q) signalling events—EDNRA—migraine	7.52e-05	0.00427	CbGpPWpGaD
Reboxetine—Agitation—Topiramate—migraine	7.5e-05	0.000778	CcSEcCtD
Reboxetine—Dyspepsia—Timolol—migraine	7.48e-05	0.000776	CcSEcCtD
Reboxetine—Hypotension—Gabapentin—migraine	7.4e-05	0.000767	CcSEcCtD
Reboxetine—Decreased appetite—Timolol—migraine	7.39e-05	0.000767	CcSEcCtD
Reboxetine—Malaise—Topiramate—migraine	7.36e-05	0.000764	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Timolol—migraine	7.34e-05	0.000761	CcSEcCtD
Reboxetine—Vertigo—Topiramate—migraine	7.33e-05	0.000761	CcSEcCtD
Reboxetine—Syncope—Topiramate—migraine	7.32e-05	0.000759	CcSEcCtD
Reboxetine—Leukopenia—Topiramate—migraine	7.31e-05	0.000758	CcSEcCtD
Reboxetine—Palpitations—Topiramate—migraine	7.21e-05	0.000748	CcSEcCtD
Reboxetine—CYP2D6—brain—migraine	7.18e-05	0.00621	CbGeAlD
Reboxetine—Loss of consciousness—Topiramate—migraine	7.17e-05	0.000744	CcSEcCtD
Reboxetine—Insomnia—Gabapentin—migraine	7.16e-05	0.000743	CcSEcCtD
Reboxetine—ABCB1—head—migraine	7.13e-05	0.00617	CbGeAlD
Reboxetine—Paraesthesia—Gabapentin—migraine	7.11e-05	0.000738	CcSEcCtD
Reboxetine—Dyspnoea—Gabapentin—migraine	7.06e-05	0.000732	CcSEcCtD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—migraine	7.05e-05	0.00401	CbGpPWpGaD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—migraine	7.05e-05	0.00401	CbGpPWpGaD
Reboxetine—Hypertension—Topiramate—migraine	7.05e-05	0.000731	CcSEcCtD
Reboxetine—Somnolence—Gabapentin—migraine	7.04e-05	0.00073	CcSEcCtD
Reboxetine—Hypersensitivity—Valproic Acid—migraine	7.04e-05	0.00073	CcSEcCtD
Reboxetine—Feeling abnormal—Timolol—migraine	7.01e-05	0.000727	CcSEcCtD
Reboxetine—Dyspepsia—Gabapentin—migraine	6.97e-05	0.000723	CcSEcCtD
Reboxetine—Gastrointestinal pain—Timolol—migraine	6.95e-05	0.000721	CcSEcCtD
Reboxetine—Chest pain—Topiramate—migraine	6.95e-05	0.000721	CcSEcCtD
Reboxetine—HTR2C—GPCR ligand binding—HTR1D—migraine	6.93e-05	0.00393	CbGpPWpGaD
Reboxetine—Anxiety—Topiramate—migraine	6.93e-05	0.000718	CcSEcCtD
Reboxetine—Unspecified disorder of skin and subcutaneous tissue—Topiramate—migraine	6.9e-05	0.000716	CcSEcCtD
Reboxetine—Decreased appetite—Gabapentin—migraine	6.88e-05	0.000714	CcSEcCtD
Reboxetine—Discomfort—Topiramate—migraine	6.87e-05	0.000712	CcSEcCtD
Reboxetine—Asthenia—Valproic Acid—migraine	6.85e-05	0.000711	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Gabapentin—migraine	6.84e-05	0.000709	CcSEcCtD
Reboxetine—Dry mouth—Topiramate—migraine	6.8e-05	0.000705	CcSEcCtD
Reboxetine—Constipation—Gabapentin—migraine	6.77e-05	0.000702	CcSEcCtD
Reboxetine—ABCB1—nervous system—migraine	6.76e-05	0.00585	CbGeAlD
Reboxetine—Urticaria—Timolol—migraine	6.76e-05	0.000701	CcSEcCtD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EDNRA—migraine	6.73e-05	0.00382	CbGpPWpGaD
Reboxetine—Abdominal pain—Timolol—migraine	6.72e-05	0.000697	CcSEcCtD
Reboxetine—Body temperature increased—Timolol—migraine	6.72e-05	0.000697	CcSEcCtD
Reboxetine—Confusional state—Topiramate—migraine	6.72e-05	0.000697	CcSEcCtD
Reboxetine—Infection—Topiramate—migraine	6.62e-05	0.000687	CcSEcCtD
Reboxetine—Shock—Topiramate—migraine	6.55e-05	0.00068	CcSEcCtD
Reboxetine—Diarrhoea—Valproic Acid—migraine	6.54e-05	0.000678	CcSEcCtD
Reboxetine—Nervous system disorder—Topiramate—migraine	6.53e-05	0.000678	CcSEcCtD
Reboxetine—Feeling abnormal—Gabapentin—migraine	6.53e-05	0.000677	CcSEcCtD
Reboxetine—ABCB1—central nervous system—migraine	6.51e-05	0.00563	CbGeAlD
Reboxetine—Tachycardia—Topiramate—migraine	6.5e-05	0.000674	CcSEcCtD
Reboxetine—Gastrointestinal pain—Gabapentin—migraine	6.48e-05	0.000672	CcSEcCtD
Reboxetine—Skin disorder—Topiramate—migraine	6.47e-05	0.000671	CcSEcCtD
Reboxetine—Hyperhidrosis—Topiramate—migraine	6.44e-05	0.000668	CcSEcCtD
Reboxetine—HTR2C—GPCR ligand binding—HTR2B—migraine	6.44e-05	0.00366	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1B—migraine	6.43e-05	0.00365	CbGpPWpGaD
Reboxetine—ABCB1—cerebellum—migraine	6.36e-05	0.0055	CbGeAlD
Reboxetine—Anorexia—Topiramate—migraine	6.35e-05	0.000659	CcSEcCtD
Reboxetine—Dizziness—Valproic Acid—migraine	6.32e-05	0.000655	CcSEcCtD
Reboxetine—Urticaria—Gabapentin—migraine	6.29e-05	0.000653	CcSEcCtD
Reboxetine—Hypersensitivity—Timolol—migraine	6.26e-05	0.00065	CcSEcCtD
Reboxetine—Abdominal pain—Gabapentin—migraine	6.26e-05	0.000649	CcSEcCtD
Reboxetine—Body temperature increased—Gabapentin—migraine	6.26e-05	0.000649	CcSEcCtD
Reboxetine—Hypotension—Topiramate—migraine	6.23e-05	0.000646	CcSEcCtD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1A—migraine	6.19e-05	0.00351	CbGpPWpGaD
Reboxetine—Asthenia—Timolol—migraine	6.1e-05	0.000633	CcSEcCtD
Reboxetine—Vomiting—Valproic Acid—migraine	6.07e-05	0.00063	CcSEcCtD
Reboxetine—Insomnia—Topiramate—migraine	6.03e-05	0.000625	CcSEcCtD
Reboxetine—Rash—Valproic Acid—migraine	6.02e-05	0.000625	CcSEcCtD
Reboxetine—Dermatitis—Valproic Acid—migraine	6.02e-05	0.000624	CcSEcCtD
Reboxetine—Headache—Valproic Acid—migraine	5.98e-05	0.000621	CcSEcCtD
Reboxetine—Paraesthesia—Topiramate—migraine	5.98e-05	0.00062	CcSEcCtD
Reboxetine—Dyspnoea—Topiramate—migraine	5.94e-05	0.000616	CcSEcCtD
Reboxetine—Somnolence—Topiramate—migraine	5.92e-05	0.000614	CcSEcCtD
Reboxetine—Dyspepsia—Topiramate—migraine	5.86e-05	0.000608	CcSEcCtD
Reboxetine—Hypersensitivity—Gabapentin—migraine	5.83e-05	0.000605	CcSEcCtD
Reboxetine—Diarrhoea—Timolol—migraine	5.82e-05	0.000603	CcSEcCtD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—EDNRA—migraine	5.82e-05	0.0033	CbGpPWpGaD
Reboxetine—Decreased appetite—Topiramate—migraine	5.79e-05	0.000601	CcSEcCtD
Reboxetine—Gastrointestinal disorder—Topiramate—migraine	5.75e-05	0.000597	CcSEcCtD
Reboxetine—Constipation—Topiramate—migraine	5.7e-05	0.000591	CcSEcCtD
Reboxetine—Asthenia—Gabapentin—migraine	5.68e-05	0.000589	CcSEcCtD
Reboxetine—Nausea—Valproic Acid—migraine	5.67e-05	0.000589	CcSEcCtD
Reboxetine—Dizziness—Timolol—migraine	5.62e-05	0.000583	CcSEcCtD
Reboxetine—ABCB1—Transmembrane transport of small molecules—TRPM8—migraine	5.58e-05	0.00317	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1B—migraine	5.51e-05	0.00313	CbGpPWpGaD
Reboxetine—Feeling abnormal—Topiramate—migraine	5.49e-05	0.000569	CcSEcCtD
Reboxetine—Gastrointestinal pain—Topiramate—migraine	5.45e-05	0.000565	CcSEcCtD
Reboxetine—Diarrhoea—Gabapentin—migraine	5.42e-05	0.000562	CcSEcCtD
Reboxetine—Vomiting—Timolol—migraine	5.41e-05	0.000561	CcSEcCtD
Reboxetine—HTR2C—GPCR downstream signaling—CALCRL—migraine	5.39e-05	0.00306	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—RAMP1—migraine	5.39e-05	0.00306	CbGpPWpGaD
Reboxetine—Rash—Timolol—migraine	5.36e-05	0.000556	CcSEcCtD
Reboxetine—Dermatitis—Timolol—migraine	5.36e-05	0.000556	CcSEcCtD
Reboxetine—Headache—Timolol—migraine	5.33e-05	0.000553	CcSEcCtD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1A—migraine	5.3e-05	0.00301	CbGpPWpGaD
Reboxetine—Urticaria—Topiramate—migraine	5.29e-05	0.000549	CcSEcCtD
Reboxetine—Abdominal pain—Topiramate—migraine	5.27e-05	0.000546	CcSEcCtD
Reboxetine—Body temperature increased—Topiramate—migraine	5.27e-05	0.000546	CcSEcCtD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR7—migraine	5.24e-05	0.00297	CbGpPWpGaD
Reboxetine—Dizziness—Gabapentin—migraine	5.24e-05	0.000543	CcSEcCtD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TAC1—migraine	5.22e-05	0.00297	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—NPS—migraine	5.22e-05	0.00297	CbGpPWpGaD
Reboxetine—ABCB1—brain—migraine	5.17e-05	0.00447	CbGeAlD
Reboxetine—Nausea—Timolol—migraine	5.05e-05	0.000524	CcSEcCtD
Reboxetine—Vomiting—Gabapentin—migraine	5.03e-05	0.000522	CcSEcCtD
Reboxetine—Rash—Gabapentin—migraine	4.99e-05	0.000518	CcSEcCtD
Reboxetine—Dermatitis—Gabapentin—migraine	4.99e-05	0.000517	CcSEcCtD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—EDNRA—migraine	4.98e-05	0.00283	CbGpPWpGaD
Reboxetine—Headache—Gabapentin—migraine	4.96e-05	0.000515	CcSEcCtD
Reboxetine—Hypersensitivity—Topiramate—migraine	4.91e-05	0.000509	CcSEcCtD
Reboxetine—HTR2C—Signaling by GPCR—RAMP1—migraine	4.89e-05	0.00278	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CALCRL—migraine	4.89e-05	0.00278	CbGpPWpGaD
Reboxetine—Asthenia—Topiramate—migraine	4.78e-05	0.000496	CcSEcCtD
Reboxetine—ABCB1—HIF-1-alpha transcription factor network—FOS—migraine	4.77e-05	0.00271	CbGpPWpGaD
Reboxetine—HTR2C—G alpha (q) signalling events—HTR2A—migraine	4.74e-05	0.00269	CbGpPWpGaD
Reboxetine—Nausea—Gabapentin—migraine	4.7e-05	0.000488	CcSEcCtD
Reboxetine—Diarrhoea—Topiramate—migraine	4.56e-05	0.000473	CcSEcCtD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR7—migraine	4.49e-05	0.00255	CbGpPWpGaD
Reboxetine—Dizziness—Topiramate—migraine	4.41e-05	0.000457	CcSEcCtD
Reboxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—migraine	4.24e-05	0.00241	CbGpPWpGaD
Reboxetine—Vomiting—Topiramate—migraine	4.24e-05	0.000439	CcSEcCtD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ATP1A3—migraine	4.23e-05	0.0024	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—ATP1A2—migraine	4.23e-05	0.0024	CbGpPWpGaD
Reboxetine—Rash—Topiramate—migraine	4.2e-05	0.000436	CcSEcCtD
Reboxetine—Dermatitis—Topiramate—migraine	4.2e-05	0.000435	CcSEcCtD
Reboxetine—HTR2C—GPCR ligand binding—HTR1B—migraine	4.2e-05	0.00238	CbGpPWpGaD
Reboxetine—Headache—Topiramate—migraine	4.17e-05	0.000433	CcSEcCtD
Reboxetine—HTR2C—GPCR ligand binding—HTR1A—migraine	4.04e-05	0.00229	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—NPS—migraine	3.98e-05	0.00226	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—TAC1—migraine	3.98e-05	0.00226	CbGpPWpGaD
Reboxetine—Nausea—Topiramate—migraine	3.96e-05	0.00041	CcSEcCtD
Reboxetine—HTR2C—GPCR downstream signaling—HTR1D—migraine	3.91e-05	0.00222	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—EDNRA—migraine	3.79e-05	0.00215	CbGpPWpGaD
Reboxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—migraine	3.67e-05	0.00208	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—CALCA—migraine	3.65e-05	0.00207	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR2B—migraine	3.64e-05	0.00207	CbGpPWpGaD
Reboxetine—ABCB1—Transmembrane transport of small molecules—HTR3A—migraine	3.59e-05	0.00204	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR1D—migraine	3.55e-05	0.00202	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HTR7—migraine	3.42e-05	0.00194	CbGpPWpGaD
Reboxetine—SLC6A4—SIDS Susceptibility Pathways—TNF—migraine	3.4e-05	0.00193	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR2B—migraine	3.3e-05	0.00188	CbGpPWpGaD
Reboxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—migraine	3.14e-05	0.00178	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—migraine	3.02e-05	0.00171	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—RAMP1—migraine	2.89e-05	0.00164	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CALCRL—migraine	2.89e-05	0.00164	CbGpPWpGaD
Reboxetine—HTR2C—GPCR ligand binding—HTR2A—migraine	2.39e-05	0.00136	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR1B—migraine	2.37e-05	0.00135	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR1A—migraine	2.28e-05	0.0013	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—migraine	2.26e-05	0.00128	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—TAC1—migraine	2.25e-05	0.00128	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—NPS—migraine	2.25e-05	0.00128	CbGpPWpGaD
Reboxetine—ABCB1—Allograft Rejection—TNF—migraine	2.22e-05	0.00126	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR1B—migraine	2.15e-05	0.00122	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—EDNRA—migraine	2.14e-05	0.00122	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR1D—migraine	2.1e-05	0.00119	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR1A—migraine	2.07e-05	0.00118	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—CALCA—migraine	2.06e-05	0.00117	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—TAC1—migraine	2.04e-05	0.00116	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—NPS—migraine	2.04e-05	0.00116	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR2B—migraine	1.95e-05	0.00111	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—EDNRA—migraine	1.95e-05	0.00111	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR7—migraine	1.93e-05	0.0011	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—CALCA—migraine	1.87e-05	0.00106	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR7—migraine	1.75e-05	0.000996	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—LRP1—migraine	1.72e-05	0.000976	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—CACNA1A—migraine	1.43e-05	0.000812	CbGpPWpGaD
Reboxetine—HTR2C—GPCR downstream signaling—HTR2A—migraine	1.35e-05	0.000768	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—CACNA1A—migraine	1.35e-05	0.000766	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NOTCH4—migraine	1.32e-05	0.000749	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR1B—migraine	1.27e-05	0.000722	CbGpPWpGaD
Reboxetine—HTR2C—Signaling by GPCR—HTR2A—migraine	1.23e-05	0.000697	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR1A—migraine	1.22e-05	0.000695	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—PGR—migraine	1.21e-05	0.000685	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TAC1—migraine	1.21e-05	0.000685	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NPS—migraine	1.21e-05	0.000685	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—EDNRA—migraine	1.15e-05	0.000653	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—NOTCH3—migraine	1.12e-05	0.000637	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—CALCA—migraine	1.11e-05	0.000629	CbGpPWpGaD
Reboxetine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—migraine	1.1e-05	0.000622	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR7—migraine	1.04e-05	0.000588	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—TGFBR2—migraine	8.92e-06	0.000506	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—CACNA1A—migraine	8.81e-06	0.0005	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—HTR2A—migraine	7.25e-06	0.000412	CbGpPWpGaD
Reboxetine—HTR2C—Signaling Pathways—ESR1—migraine	6.44e-06	0.000366	CbGpPWpGaD
Reboxetine—ABCB1—Metabolism—MTHFR—migraine	4.73e-06	0.000269	CbGpPWpGaD
Reboxetine—CYP2D6—Metabolism—MTHFR—migraine	4.46e-06	0.000253	CbGpPWpGaD
Reboxetine—CYP3A4—Metabolism—MTHFR—migraine	2.92e-06	0.000166	CbGpPWpGaD
